Trial intelligence / Profile preview

Desmopressin for nocturnal polyuria in idiopathic Parkinson's syndrome (cross-over, placebo-controlled)

2008-003966-25Phase 4Completed

Sponsor
University Medical Center Mainz, Department of Neurology
Start
Nov 2008
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of desmopressin in Parkinson's disease (PD) and nocturnal polyuria (NP) (2 arms), sponsored by University Medical Center Mainz, Department of Neurology. Primary endpoint: Average nocturnal micturition frequency. Started Nov 2008; status: completed.

02

Drugs

desmopressin
03

Conditions

Parkinson's disease (PD)nocturnal polyuria (NP)

Beyond the preview

Go deeper on 2008-003966-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003966-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call